Gout - Current Treatment - Detailed, Expanded Analysis: Treatment Algorithms: Claims Data Analysis (US) - Research and Reports - Clarivate
Gout is a chronic arthritic condition caused by elevated serum uric acid (sUA) characterized by intermittent acute flares. Treatment of the painful acute flares is distinct from the chronic management of hyperuricemia with urate-lowering therapies and is not considered in this study. The aim of chronic treatment is to reduce the number and severity of acute flares and damage to the affected joints. Xanthine oxidase inhibitors (XOIs) are the mainstay of chronic gout treatment, with generic allopurinol prescribed extensively.
How has Krystexxa been integrated into the treatment algorithm, and what is its source of business?
Key companies: Horizon Pharma, Takeda Pharmaceuticals, Cardinal Health
Key drugs: Krystexxa, febuxostat, allopurinol, probenecid, probenecid /colchicine
Gout - Current Treatment - Detailed, Expanded Analysis: Treatment Algorithms: Claims Data Analysis (US)
Treatment Algorithms CDA Gout US April 2021
Treatment Algorithms CDA Gout US 2021 Dashboard
Gout Current Treatment Treatment Algorithms: Claims Data Analysis US